Stocks · Health care · Pharmaceutical Preparations

Erasca, Inc.

ERAS Clue Score37

United States Fiscal year ends December CIK 0001761918 Results filed 11 Aug 2026

Add to watchlist

What the insiders did Net buying

By person

12 insiders · 25 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Bihua Chen

Director

$21.62M (3)

$3.75M (1)

+$17.87M

10,813,246

3.09%

$177.34M

+1,081,324,500%

Jonathan E Lim

Chairman & CEO

$4.71M (7)

—

+$4.71M

12,899,360

3.69%

$211.55M

+56,124%

Ebun Garner

Chief Legal Officer

$14.40K (1)

$1.98M (2) scheduled

−$1.97M

25,076

0.0072%

$411.25K

—

Alexander W. Casdin

Director

$384.43K (4)

—

+$384.43K

573,974

0.1641%

$9.41M

+109.5%

Shannon Morris

Chief Medical Officer

—

$300.76K (1) scheduled

−$300.76K

0

0.0000%

$0.00

—

Pratik S Multani

Director

$99.20K (1)

—

+$99.20K

172,866

0.0494%

$2.84M

+3.7%

Valerie Denise Harding Start

Director

$96.88K (3)

—

+$96.88K

22,000

0.0063%

$360.80K

—

Julie Hambleton

Director

$96.00K (1)

—

+$96.00K

6,000

0.0017%

$98.40K

—

James Arthur Bristol

Director

$82.80K (1)

—

+$82.80K

20,000

0.0057%

$328.00K

—

ARCH Venture Partners X, LLC entity

10% owner

—

—

—

5,527,777

1.58%

$90.66M

—

Lin Wei

Chief Medical Officer

—

—

—

315,812

0.0903%

$5.18M

+1.1%

David M. Chacko

CFO and CBO

—

—

—

279,980

0.0800%

$4.59M

+18.7%